Journal rankings · indicator year 2000
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2000
Pharmacology, Toxicology and Pharmaceutics journal rankings 2000
23 ranked journals · Field in Life Sciences
Pharmacology, Toxicology and Pharmaceutics has 23 ranked journals in 2000. The median journal has an OJR of 0.62, below the world average of 1.00; Q1 starts at OJR 1.10. The top three are Critical Reviews in Therapeutic Drug Carrier Systems, Pharmacogenetics, and Drug Safety.
Ranks and citation indicators: 2000. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 1997–1999, the window the 2000 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Pharmacology, Toxicology and Pharmaceutics (4)
Up to Life Sciences23 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 1999. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 1997–1999, the window the 2000 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 1997–1999 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2000. | Compare |
|---|---|---|---|---|---|---|---|
1Critical Reviews in Therapeutic Drug Carrier SystemsBegell House · United States | 2.58Q1 | 3.46no 1999 value | 36 | 0% | — | — | |
2PharmacogeneticsLippincott Williams & Wilkins · United Kingdom | 2.21Q1 | 4.41no 1999 value | 206 | 0% | — | — | |
3Drug SafetyAdis, Springer Healthcare · New Zealand | 1.94Q1 | 3.18no 1999 value | 223 | 1% | $4,990 | — | |
4Pharmaceutical ResearchSpringer Science+Business Media · United States | 1.30Q1 | 2.22no 1999 value | 888 | 3% | $4,690 | — | |
5Drug Metabolism and DispositionAmerican Society for Pharmacology and Experimental Therapeutics · United States | 1.15Q1 | 2.11no 1999 value | 238 | 2% | $3,500 | — | |
6Journal of Analytical ToxicologyOxford University Press · United Kingdom | 1.10Q1 | 1.82no 1999 value | 339 | 32% | $4,823 | — | |
7XenobioticaTaylor & Francis · United Kingdom | 1.00Q2 | 1.98no 1999 value | 290 | 1% | — | — | |
8European Journal of Pharmaceutics and BiopharmaceuticsElsevier BV · Netherlands | 0.79Q2 | 1.11no 1999 value | 235 | 6% | $4,210 | — | |
9Journal of MicroencapsulationTaylor & Francis · United Kingdom | 0.68Q2 | 1.04no 1999 value | 199 | 1% | — | — | |
10International Journal of PharmaceuticsElsevier BV · Netherlands | 0.68Q2 | 1.03no 1999 value | 1,158 | 2% | $4,650 | — | |
11European Journal of Pharmaceutical SciencesOAElsevier BV · Netherlands | 0.67Q2 | 1.12no 1999 value | 194 | 1% | $3,070 | — | |
12Journal of Fluorine ChemistryElsevier BV · Netherlands | 0.62Q2 | 0.81no 1999 value | 648 | 2% | $3,660 | — | |
13Pharmaceutical Science & Technology TodayElsevier BV · United Kingdom | 0.59Q3 | 0.77no 1999 value | 173 | 0% | — | — | |
14Pharmaceutical Development and TechnologyTaylor & Francis · United States | 0.57Q3 | 0.63no 1999 value | 203 | 3% | — | — | |
15Drug Development and Industrial PharmacyTaylor & Francis · United States | 0.52Q3 | 0.66no 1999 value | 481 | 1% | — | — | |
16Biopharmaceutics & Drug DispositionWiley · United Kingdom | 0.38Q3 | 0.74no 1999 value | 122 | 0% | $3,800 | — | |
17Drug DeliveryOATaylor & Francis · United Kingdom | 0.36Q3 | 0.55no 1999 value | 105 | 95% | $2,864 | — | |
18European Journal of Drug Metabolism and PharmacokineticsAdis, Springer Healthcare · France | 0.34Q3 | 0.56no 1999 value | 199 | 2% | $2,690 | — | |
19Drug metabolism and drug interactionsDe Gruyter · Germany | 0.27Q4 | 0.42no 1999 value | 48 | 0% | — | — | |
20Journal of Pharmaceutical Marketing & ManagementHaworth Press · United States | 0.24Q4 | 0.17no 1999 value | 73 | 10% | — | — | |
21Dissolution TechnologiesUnited States | 0.23Q4 | 0.15no 1999 value | 46 | 0% | — | — | |
22YAKUGAKU ZASSHIOAPharmaceutical Society of Japan · Japan | 0.17Q4 | 0.25no 1999 value | 231 | 92% | — | — | |
23Journal of Pharmaceutical InvestigationSpringer Science+Business Media · South Korea | 0.02Q4 | 0.00no 1999 value | 83 | 0% | $3,890 | — |
Subfields of Pharmacology, Toxicology and Pharmaceutics, compared.
Journals
Citations made in 2000. Corpus-wide, 66.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
10 additional Pharmacology, Toxicology and Pharmaceutics journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 1997–1999, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2000. Publication window: 1997–1999. How these summaries are calculated
- Ranked journals
- 23
- Window papers (baseline)
- 20,428 Change unavailable from indicator year 1997
- Median OJR
- 0.620 Change unavailable from indicator year 1997
- Rising journals (2025)
- 4Comparison-group list (4)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 1997–1999 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 23 | 27 | 30 | 32 | 32 | 34 | 37 | 38 | 40 | 43 | 44 | 49 | 54 | 61 | 69 | 71 | 74 | 71 | 73 | 75 | 70 | 72 | 75 | 73 | 72 | 68 | |
| Window papers (baseline) | 20,428 | 21,714 | 23,158 | 25,397 | 26,889 | 29,157 | 31,606 | 34,777 | 38,146 | 41,640 | 45,814 | 49,553 | 53,613 | 56,245 | 59,173 | 59,681 | 59,061 | 56,321 | 53,536 | 51,719 | 51,606 | 54,267 | 56,608 | 57,539 | 56,944 | 58,541 | |
| Median OJR | 0.620 | 0.717 | 0.722 | 0.88 | 0.86 | 0.83 | 0.91 | 1.11 | 0.9471 | 0.97 | 0.949 | 1.03 | 0.9469 | 0.80 | 0.70 | 0.720 | 0.61 | 0.7184 | 0.74 | 0.628 | 0.77 | 0.621 | 0.67 | 0.630 | 0.625 | 0.7176 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 2.7% | 62 journals |
| Retracted papers per 1,000 | Pooled rate: 1.221 per 1,000 | 51 journals |
| Output growth | Median: -1.6% | 60 journals |
| Open access share | Median: 44.5% | 68 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,605 | 32 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 22.2% | 67 journals |
| Review share | Median: 0.4% | 68 journals |
| Articles-only OJR | Median: 0.74 | 68 journals |
| Uncited share | Median: 25.2% | 68 journals |
| Citation concentration | Median: 43.7% | 68 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.